Back
Recursion Pharmaceuticals Stock Price Chart
Buy
64
RXRX
Recursion Pharmaceuticals
Last Price:
8.35
Seasonality Move:
17.3%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Recursion Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.16 | Sell |
| 20-day SMA: | 9.15 | Sell |
| 50-day SMA: | 8.92 | Sell |
| 200-day SMA: | 8.91 | Sell |
| 8-day EMA: | 9.04 | Sell |
| 20-day EMA: | 9.04 | Sell |
| 50-day EMA: | 9.2 | Sell |
| 200-day EMA: | 9.25 | Sell |
Recursion Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 47.66 | Sell |
| Chaikin Money Flow: | 2310440 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.33 - 9.53) | Sell |
| Bollinger Bands (100): | (8.36 - 11.82) | Sell |
Recursion Pharmaceuticals Technical Analysis
| May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Recursion Pharmaceuticals Stock
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 8.87 while RXRX 8-day simple moving average is 9.16, which is a Sell signal.
- The stock price of RXRX is 8.87 while Recursion Pharmaceuticals 20-day SMA is 9.15, which makes it a Sell.
- Recursion Pharmaceuticals 50-day simple moving average is 8.92 while RXRX share price is 8.87, making it a Sell technically.
- RXRX stock price is 8.87 and Recursion Pharmaceuticals 200-day simple moving average is 8.91, creating a Sell signal.
RXRX Technical Analysis vs Fundamental Analysis
Buy
64
Recursion Pharmaceuticals (RXRX)
is a Buy
Is Recursion Pharmaceuticals a Buy or a Sell?
-
Recursion Pharmaceuticals stock is rated a Buy
The current Recursion Pharmaceuticals [RXRX] share price is $8.87. The Score for RXRX is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
Recursion Pharmaceuticals Stock Info
Market Cap:
2.11B
Price in USD:
8.87
Share Volume:
3.36M
Recursion Pharmaceuticals 52-Week Range
52-Week High:
16.75
52-Week Low:
4.97
Buy
64
Recursion Pharmaceuticals (RXRX)
is a Buy
Recursion Pharmaceuticals Share Price Forecast
-
What is the Recursion Pharmaceuticals stock price today?
The Recursion Pharmaceuticals stock price is 8.87 USD today. -
Will RXRX stock go up or go down?
Recursion Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Recursion Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Recursion Pharmaceuticals is not overvalued.
Is Recursion Pharmaceuticals Stock a Buy?
- Recursion Pharmaceuticals share price is 8.87 while RXRX 8-day exponential moving average is 9.04, which is a Sell signal.
- The stock price of RXRX is 8.87 while Recursion Pharmaceuticals 20-day EMA is 9.04, which makes it a Sell.
- Recursion Pharmaceuticals 50-day exponential moving average is 9.20 while RXRX share price is 8.87, making it a Sell technically.
- RXRX stock price is 8.87 and Recursion Pharmaceuticals 200-day simple moving average is 9.25, creating a Sell signal.
Fundamental Analysis of Recursion Pharmaceuticals
Is Recursion Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.25 per share, a decrease this year of $0.03 per share, and a decrease next year of $0.15 per share.
Technical Analysis of Recursion Pharmaceuticals
Should I short Recursion Pharmaceuticals stock?
- RXRX Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Recursion Pharmaceuticals is a Buy
- Recursion Pharmaceuticals Relative Strength Index (RSI) is 47.66, which suggest Recursion Pharmaceuticals is oversold
- The Bollinger Bands (25) for Recursion Pharmaceuticals is (8.33 - 9.53), which suggest Recursion Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Recursion Pharmaceuticals is (8.36 - 11.82), which suggest Recursion Pharmaceuticals is a Sell
* Recursion Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.